Edaravone Injection
Product Images NDC 0781-3527

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Edaravone (NDC 0781-3527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure (Edaravone 01)

Chem-structure (Edaravone 01)
Chemical structure diagram of Edaravone, showing its molecular framework including a pyrazolone ring with a ketone group, methyl substitution, and a phenyl ring attached to a nitrogen atom.*
FDA Label Image

Figure-1 (Edaravone 02)

Figure-1 (Edaravone 02)
A bar graph comparing the percent of patients at different ranges of change in ALSFRS-R scores at week 24 between Edaravone Injection and placebo groups. The x-axis shows the range of score changes from -21 to 2, with arrows indicating 'Worse' to 'Better' outcomes. The y-axis represents the percentage of patients from 0 to 30%. Black bars represent Edaravone Injection, and white bars represent placebo, showing distribution differences in patient outcomes.*
FDA Label Image

Carton (Edaravone 03)

Carton (Edaravone 03)
Edaravone Injection 30 mg/100 mL (0.3 mg/mL) intravenous infusion sterile solution in a 100 mL x 2 bags package. Each 100 mL single-dose bag contains 30 mg edaravone and related excipients, with instructions to infuse over 30 minutes. Labeler is Sandoz Inc, NDC 0781-3527, with storage and usage cautions included on the carton.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.